Jobevne™ Gets Green Light: Biocon Biologics Powers Ahead in Biosimilars Revolution

Unknown Apr 02, 2026 800 Views

Biocon Biologics Ltd (BBL), which is part of Biocon Ltd, has received approval from the U.S. Food and Drug Administration (FDA) for the intravenous use of Jobevne™ (bevacizumab-nwgd), a biosimilar to Avastin® (bevacizumab). This is an important milestone for Biocon Biologics because, wi...